Browsing by Subject
Ara mostrant els elements 1-20 d 62
-
COAST: An Open-Label, Phase II, Multidrug Platform Study of Durvalumab Alone or in Combination With Oleclumab or Monalizumab in Patients With Unresectable, Stage III Non–Small-Cell Lung Cancer
(American Society of Clinical Oncology, 2022-10-10) -
Comorbidity between lung cancer and COVID-19 pneumonia: role of immunoregulatory gene transcripts in high ACE2-expressing normal lung
(SAGE Publications, 2022-10-28) -
DSTYK inhibition increases the sensitivity of lung cancer cells to T cell–mediated cytotoxicity
(Rockefeller University Press, 2022-12-05)